FDA Investigator: Jeremy L. Wally
- Jeremy L. Wally first started conducting FDA inspections in 2014, with the last inspection in 2024. Over that time, Jeremy L. Wally has conducted 10 inspections at 9 companies across 9 sites.
Get Jeremy Wally's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Emergent Manufacturing Operations Baltimore | 2021
Available Now - $199
Jeremy L. Wally
Biologic Form 483
FDA 483 Pace Analytical Inc., San German | 2024
Out-of-stock
Jeremy L. Wally
Biologics Form 483
FDA 483 Citra Labs LLC., Braintree | 2024
Out-of-stock
Jeremy L. Wally
Biologics Form 483
FDA 483 Merck Sharpe & Dohme Corp, West Point | 2015
Out-of-stock
Jeremy L. Wally
Biologic Form 483
FDA 483 Ipsen BioPharm Ltd, Wrexham | 2014
Out-of-stock
Jeremy L. Wally
Biologic Form 483
FDA 483 Merck Sharp & Dohme Corp., Durham | 2014
Out-of-stock
Jeremy L. Wally
Biologic Form 483
Co-Investigators (12)
- Jonah S. Ufferfilge, FDA Investigator
- Priscilla M. Pastrana, FDA Investigator
- Susan M. Jackson, FDA Investigator
- Cody D. Rickman, FDA Investigator
- Debra M. Emerson, FDA Investigator
- Chad R. Burger, FDA Investigator
- Ellen Huang, FDA Investigator
- Randa Melhem, FDA Investigator
- Qiao Y. Bobo, FDA Investigator
- Seneca D. Toms, FDA Investigator
- Robert D. Tollefsen, FDA Investigator
- Destry M. Sillivan, FDA Investigator